Japan's Nikkei fell in choppy trade on Friday as financial stocks languished, reflecting more cautious U.S. monetary policy, while the drug sector tumbled after Eisai and Biogen said they will end their Alzheimer's drug trials.
The Nikkei share average fell 0.2 percent to 21,563.09 points by the midday break, after flitting in and out of positive and negative territory. The broader Topix dipped 0.1 percent to 1,612.64.
Financial stocks faced a sell-off after the spread between the three-month Treasury bill yield and the 10-year note yield shrank to its narrowest level since August 2007 on Thursday in the wake of the U.S. Federal Reserve's decision to cease tightening monetary policy.
Source : Reuters